December 15, 2025: MDL Created for Ozempic Vision Loss Lawsuits In a significant move, the Judicial Panel on Multidistrict Litigation has approved the creation of a new MDL for Ozempic vision loss lawsuits
If I could give Eddie Hughes 10 stars instead of 5, I absolutely would
In accordance, emerging therapies act through diverse mechanisms, such as inhibition of DNA repair enzymes, modulation of neuronal excitability, suppression of purinergic signaling, prevention of cytoskeletal degradation and attenuation of nociceptive transmission, each representing a distinct strategy in addressing the complex pathophysiology of neuropathic pain (Table 4)
Currently, GLP-1 receptor agonist products on the market are all injectable forms
These medications have been game changers in both obesity and diabetes management
Is it expired now